Skip to main content
Home Start-Ups Page 4

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

https://dws-test-02.oit.duke.edu/wp-content/uploads/2024/09/FY2024-Press-Release-featured-image-v2.png

Duke Inventions Bring $82.6M in Revenue and Launch 6 New Start-Ups

$82.6M in revenue. 94 patents issued. 302 new invention disclosures. In a down year for new disclosures, OTC focuses on investing in the future.

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2023/08/Sparta_Biomedical__Logo.jpg

Sparta Biomedical Reports Treatment of First Patients with Breakthrough Device, Ormi

Sparta Biomedical, a Duke start-up and Duke Capital Partners portfolio company, was founded around technology developed by lead inventor Professor Benjamin Wiley (Chemistry, Trinity), along with Professor Ken Gall (MEMS, Pratt), Professor Matt Becker (Chemistry, Trinity), and colleagues.

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2024/02/basking-biosciences-logo.png

Basking Biosciences Doses First Patients in Phase 2 Clinical Trial of Reversible Thrombolytic BB-031 for Acute Ischemic Stroke

Basking Biosciences, a start-up out of the lab of Professor Bruce Sullenger (Surgery, SOM), is developing a next-generation treatment for acute ischemic stroke.

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2024/09/adaptin-bio-cover.png

Adaptin Bio Announces FDA Clearance of IND Application for APTN-101 in Glioblastoma

Adaptin Bio is a Duke start-up based around glioblastoma-related technologies developed in the lab of Dr. John Sampson (Neurosurgery, SOM).

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2024/08/lindy-biosciences-logo.png

Lindy Biosciences Enters Licensing and Collaboration Agreement With Novartis for Multi-target Drug Delivery Innovation

Lindy Biosciences is a Duke University start-up run by CEO Deborah Bitterfield (PhD MEMS, Pratt) based on technology developed in the lab of Professor Emeritus David Needham (MEMS, Pratt).

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2024/08/David_Kasper_leaning.jpeg

Carpe, a Duke-founded Startup, Acquired by Topspin Consumer Partners

Founded by a Duke and UNC undergrad duo in 2015, Carpe creates antiperspirant solutions for consumers.

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2024/08/vq-biomedical-logo.png

VQ Biomedical receives $750K contract from BARDA / ASPR / HHS

VQ Biomedical is a start-up resulting from the collaboration of Assistant Professor Tobias Straube (Pediatrics, SOM) and Research Scientist Stewart Farling (CEE, Pratt).

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2024/06/TUSW-may-2024-featured-image.jpeg

Triangle Universities Startup Workshop: Academic Entrepreneurs Get an Intensive Course in Venture

What does it take to build a therapeutic or medical device startup? Duke, UNC, and NC State – with support from Alexandria Venture Investments – put on a three-day workshop for a select group of…

Read More

https://dws-test-02.oit.duke.edu/wp-content/uploads/2024/06/DukeMag_Summer24_science_nim_5.jpg

Meta Marketplace – Duke Magazine

Ideas from the lab of David Smith (ECE, Pratt) are showing up all over the place. Learn more about the lab's multiple spinouts.

Read More